Article
Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Apr 2010
Silvers Amy L, Lin Lin, Bass Adam J, Chen Guoan, Wang Zhuwen, Thomas Dafydd G, Lin Jules, Giordano Thomas J, Orringer Mark B, Beer David G, Chang Andrew C
Abstract excerpt
PURPOSE: The chemopreventive effects of selenium have been extensively examined, but its role in cancer development or as a chemotherapeutic agent has only recently been explored. Because selenium-binding protein 1 (SELENBP1, SBP1, hSP56) has been shown to bind selenium covalently and selenium deficiency has been associated with esophageal adenocarcinoma (EAC), we examined its role in EAC development and its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
